168 related articles for article (PubMed ID: 26526583)
1. Rapamycin inhibited the function of lung CSCs via SOX2.
Xie LX; Sun FF; He BF; Zhan XF; Song J; Chen SS; Yu SC; Ye XQ
Tumour Biol; 2016 Apr; 37(4):4929-37. PubMed ID: 26526583
[TBL] [Abstract][Full Text] [Related]
2. The Role of Cancer Stem Cells in Recurrent and Drug-Resistant Lung Cancer.
Suresh R; Ali S; Ahmad A; Philip PA; Sarkar FH
Adv Exp Med Biol; 2016; 890():57-74. PubMed ID: 26703799
[TBL] [Abstract][Full Text] [Related]
3. Sox2 inhibits Wnt-β-catenin signaling and metastatic potency of cisplatin-resistant lung adenocarcinoma cells.
He J; Shi J; Zhang K; Xue J; Li J; Yang J; Chen J; Wei J; Ren H; Liu X
Mol Med Rep; 2017 Apr; 15(4):1693-1701. PubMed ID: 28259951
[TBL] [Abstract][Full Text] [Related]
4. Cationic polyurethanes-short branch PEI-mediated delivery of Mir145 inhibited epithelial-mesenchymal transdifferentiation and cancer stem-like properties and in lung adenocarcinoma.
Chiou GY; Cherng JY; Hsu HS; Wang ML; Tsai CM; Lu KH; Chien Y; Hung SC; Chen YW; Wong CI; Tseng LM; Huang PI; Yu CC; Hsu WH; Chiou SH
J Control Release; 2012 Apr; 159(2):240-50. PubMed ID: 22285547
[TBL] [Abstract][Full Text] [Related]
5. Mammalian target of rapamycin inhibitors, temsirolimus and torin 1, attenuate stemness-associated properties and expression of mesenchymal markers promoted by phorbol-myristate-acetate and oncostatin-M in glioblastoma cells.
Chandrika G; Natesh K; Ranade D; Chugh A; Shastry P
Tumour Biol; 2017 Mar; 39(3):1010428317695921. PubMed ID: 28351321
[TBL] [Abstract][Full Text] [Related]
6. Evidence for embryonic stem-like signature and epithelial-mesenchymal transition features in the spheroid cells derived from lung adenocarcinoma.
Roudi R; Madjd Z; Ebrahimi M; Najafi A; Korourian A; Shariftabrizi A; Samadikuchaksaraei A
Tumour Biol; 2016 Sep; 37(9):11843-11859. PubMed ID: 27048287
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of cancer stem cell properties via mTOR signaling pathway inhibition by rapamycin in nasopharyngeal carcinoma.
Yang C; Zhang Y; Zhang Y; Zhang Z; Peng J; Li Z; Han L; You Q; Chen X; Rao X; Zhu Y; Liao Z
Int J Oncol; 2015 Sep; 47(3):909-17. PubMed ID: 26202311
[TBL] [Abstract][Full Text] [Related]
8. Sox2 expression involvement in the oncogenicity and radiochemoresistance of oral cancer stem cells.
Chou MY; Hu FW; Yu CH; Yu CC
Oral Oncol; 2015 Jan; 51(1):31-9. PubMed ID: 25456004
[TBL] [Abstract][Full Text] [Related]
9. The Hippo effector TAZ promotes cancer stemness by transcriptional activation of SOX2 in head neck squamous cell carcinoma.
Li J; Li Z; Wu Y; Wang Y; Wang D; Zhang W; Yuan H; Ye J; Song X; Yang J; Jiang H; Cheng J
Cell Death Dis; 2019 Aug; 10(8):603. PubMed ID: 31399556
[TBL] [Abstract][Full Text] [Related]
10. Curcumin suppresses stem-like traits of lung cancer cells via inhibiting the JAK2/STAT3 signaling pathway.
Wu L; Guo L; Liang Y; Liu X; Jiang L; Wang L
Oncol Rep; 2015 Dec; 34(6):3311-7. PubMed ID: 26397387
[TBL] [Abstract][Full Text] [Related]
11. MiR-1181 inhibits stem cell-like phenotypes and suppresses SOX2 and STAT3 in human pancreatic cancer.
Jiang J; Li Z; Yu C; Chen M; Tian S; Sun C
Cancer Lett; 2015 Jan; 356(2 Pt B):962-70. PubMed ID: 25444909
[TBL] [Abstract][Full Text] [Related]
12. SOX2-high cancer cells exhibit an aggressive phenotype, with increases in stemness, proliferation and invasion, as well as higher metabolic activity and ATP production.
Mauro-Lizcano M; Sotgia F; Lisanti MP
Aging (Albany NY); 2022 Dec; 14(24):9877-9889. PubMed ID: 36566021
[TBL] [Abstract][Full Text] [Related]
13. Side population cells separated from A549 lung cancer cell line possess cancer stem cell-like properties and inhibition of autophagy potentiates the cytotoxic effect of cisplatin.
Yang Y; Fan Y; Qi Y; Liu D; Wu K; Wen F; Zhao S
Oncol Rep; 2015 Aug; 34(2):929-35. PubMed ID: 26081992
[TBL] [Abstract][Full Text] [Related]
14. Galectin-3 modulates the EGFR signalling-mediated regulation of Sox2 expression via c-Myc in lung cancer.
Kuo HY; Hsu HT; Chen YC; Chang YW; Liu FT; Wu CW
Glycobiology; 2016 Feb; 26(2):155-65. PubMed ID: 26447186
[TBL] [Abstract][Full Text] [Related]
15. The emerging role of SOX2 in cell proliferation and survival and its crosstalk with oncogenic signaling in lung cancer.
Chou YT; Lee CC; Hsiao SH; Lin SE; Lin SC; Chung CH; Chung CH; Kao YR; Wang YH; Chen CT; Wei YH; Wu CW
Stem Cells; 2013 Dec; 31(12):2607-19. PubMed ID: 23940081
[TBL] [Abstract][Full Text] [Related]
16. Enhancing Chemosensitivity of Breast Cancer Stem Cells by Downregulating SOX2 and ABCG2 Using Wedelolactone-encapsulated Nanoparticles.
Das S; Mukherjee P; Chatterjee R; Jamal Z; Chatterji U
Mol Cancer Ther; 2019 Mar; 18(3):680-692. PubMed ID: 30587555
[TBL] [Abstract][Full Text] [Related]
17. Cucurbitacin I inhibits tumorigenic ability and enhances radiochemosensitivity in nonsmall cell lung cancer-derived CD133-positive cells.
Hsu HS; Huang PI; Chang YL; Tzao C; Chen YW; Shih HC; Hung SC; Chen YC; Tseng LM; Chiou SH
Cancer; 2011 Jul; 117(13):2970-85. PubMed ID: 21225866
[TBL] [Abstract][Full Text] [Related]
18. STAT1‑HDAC4 signaling induces epithelial‑mesenchymal transition and sphere formation of cancer cells overexpressing the oncogene, CUG2.
Kaowinn S; Kaewpiboon C; Koh SS; Krämer OH; Chung YH
Oncol Rep; 2018 Nov; 40(5):2619-2627. PubMed ID: 30226605
[TBL] [Abstract][Full Text] [Related]
19. Enrichment and characterization of cancer stem cells from a human non-small cell lung cancer cell line.
Zhao C; Setrerrahmane S; Xu H
Oncol Rep; 2015 Oct; 34(4):2126-32. PubMed ID: 26239272
[TBL] [Abstract][Full Text] [Related]
20. Combination of Sasa quelpaertensis Nakai leaf extract and cisplatin suppresses the cancer stemness and invasion of human lung cancer cells.
Kim M; Kim YS; Kim KM; Ko HC; Kim SJ; Kim JH; Kim Y
Integr Cancer Ther; 2014 Nov; 13(6):529-40. PubMed ID: 24838270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
